DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Folegatti PM, Ewer KJ, Aley PK. et al.
Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet 2020;
396 (10/249) 467-478
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.